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A 9.5-month-old boy with Down syndrome, weighing 4.8 kg, presented with history of failure to thrive. Clinically, he
had symptoms and signs of congestive heart failure. His echocardiogram showed a large perimembranous ventricular
septal defect (pmVSD) with some inlet extension covered by a large aneurysmal tissue with multiple right ventricular
(RV) exits. Additionally, he had hypothyroidism and Hirschsprung disease. Instead of closing the VSD surgically, the
VSD was successfully closed utilizing an 8  6 mm duct occluder. The baby remained in the intensive care unit for one
night. The day after the procedure, the infant was stable and showed clinical improvement. Electrocardiogram (ECG)
showed normal sinus rhythm with no evidence of heart block. Twenty-four hours later, echocardiography showed the
device was in an excellent position, with a small residual leak. There was normal tricuspid valve inflow and normal
aortic valve outflow with no significant valvar insufficiency. The baby was discharged after 3 days in stable condition.
We believe infants with such co-morbidities which might complicate their post-operative course and prolong the
intensive care unit admission, might benefit from such alternative management.
 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Transcatheter closure of ventricular septal de-fects (VSD) has not yet received general
acceptance. It is not well-established in the youn-ger age group with a weight category of less than
5 kg. Occasionally, hybrid procedure has been
proposed [1,2]. While surgical closure of VSD is
well-established, some types and locations of
VSD remain challenging [3]. Additionally, infants
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can have a difficult course. The presence of addi-
tional co-morbidities will add more risk during
the postoperative period [4]. We present an infant
with Down syndrome and other associated non-
cardiac conditions in whom it was possible to suc-
cessfully close the VSD utilizing a duct occluder.
We believe that certain types of VSD can be closed
safely by transcatheter approach even if weight is
less than 5 kg, especially if the trend of miniaturiz-
ing devices continues. This approach should be
considered as a valid alternative to a surgical
option.Case report
Our patient is a 9.5-month-old boy with Down
syndrome who presented with symptoms and
signs of congestive heart failure and failure to
thrive. His weight was 4.8 kg (less than the 5th
percentile in the Down syndrome growth chart)
and his height was 66 cm (25th percentile in Down
syndrome growth chart). He was the product of a
spontaneous vaginal delivery at full term with
birth weight of 3.2 kg. Chromosomal analysis con-
firmed the diagnosis of Down syndrome. Addi-
tionally, he was found to have hypothyroidism
and was initiated on L-thyroxine. Investigation
by rectal biopsy due to chronic constipation con-
firmed Hirschsprung disease. He underwent cor-
rective surgery by resection of the retro-sigmoid
segment at the age of 6 months.Figure 1. 2D Trans-thoracic apical view showing the ventricular septal de
right ventricular side. LA: left atrium, LV: left ventricle, RA: right atriumThe diagnosis of a ventricular septal defect
(VSD) was established at birth. He was started
on furosemide and captopril. Despite maximum
medical therapy, he continued to be in congestive
heart failure. His weight remained below the 5th
percentile throughout this course.
On examination, there were good femoral
pulses, and the liver was 4 cm below the right cos-
tal margin. There was cardiac heave and grade 2/6
systolic murmur over the left precordium. The
first heart sound was normal but the pulmonary
component of his second heart sound was slightly
loud. Chest X-ray showed cardiomegaly and in-
creased pulmonary vascularity, consistent with
significant left-to-right shunt. The electrocardio-
gram (ECG) showed normal sinus rhythm, normal
axis deviation for age and biventricular hypertro-
phy. Echocardiography (echo) showed situs sol-
itus, levocardia, intact atrial septum, mild
tricuspid regurgitation (TR) and no mitral regurgi-
tation (MR). There was a large perimembranous
VSD extending into the inlet portion with left-to-
right shunt and well-formed windsock-like aneu-
rysmal tissue that had multiple fenestrations from
the right ventricular side (Fig. 1). The peak systolic
pressure gradient across the VSD was 50 mmHg.
The VSD from the left ventricular (LV) side mea-
sured 10 mm and the largest fenestration from
right ventricle (RV) measured 5 mm. There was
evidence of volume loaded left atrium (LA) with
left atrium to aortic ratio (LA/Ao) ratio of 1.7. LV
was severely dilated with LV end-diastolic diame-fect (VSD) with aneurysmal tissue and multiple fenestrations from the
, RV: right ventricle, TV: tricuspid valve.
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good biventricular systolic function, unobstructed
right and left ventricular outflows, and unob-
structed pulmonary artery branches and left-
sided aortic arch. There was no patent ductus arte-
rious or aortic coarctation. Drainage of pulmonary
and systemic veins was normal.Management
Cardiac surgery was considered as the first
option. However, due to associated abnormalities,
cardiac surgery was deemed to carry slightly high-
er risks than ‘straight-forward’ VSD surgery. The
parents of the patient were reluctant to agree to
surgical repair and opted for cardiac catheteriza-
tion and possible device closure. The existing
aneurysmal tissue covering the VSD encouraged
us to attempt VSD closure in the catheter
laboratory with the intention of using the PFM
Le VSD coil (PFM company, Köln, Germany), a
transcatheter approach with less risk of heart
block [5].Cardiac catheterization procedure
The procedure was performed under elective
intubation and trans-esophageal echocardiogra-
phy (TEE) guidance. The intervention was done
as previously described for VSD closure using dif-
ferent devices [5]. In brief, after obtaining femoral
venous access and femoral arterial access, hemo-
dynamic assessment was first performed to obtain
pressures and saturations. The pulmonary arteryFigure 2. (A) Left ventricular (LV) angiogram from lateral projection show
release of the device, showing the duct occluder device in good position.pressure measured 28/9 mmHg with mean of
18 mmHg while the systemic pressure was 68/
24 mmHg with mean of 43 mmHg. The ratio of
pulmonary to systemic flow (Qp:Qs) was about
3:1 on room air. The LV angiogram was obtained
in 30 left anterior oblique (LAO) view and 20 cra-
nial tilt. The VSD was clearly identified and mea-
surements were obtained (Fig. 2A). The LV
angiogram was repeated while the 7 French (Fr)
long sheath was parked into the ascending aorta
across the VSD. Judging from angiograms and
TEE assessment, the defect was considered too
large and not suitable for the PFM coil. Because
of its vicinity to the tricuspid valve, we feared
the coil might get entangled in the tricuspid valve
chordae. Instead, we decided to close the VSD
using an 8  6 mm duct occluder device (AGA,
Minnesota, USA). After having established the
typical arteriovenous loop, the device was inserted
from the venous side, utilizing a 7 Fr delivery
sheath. After device implant, angiography was
performed using a 4 Fr pigtail catheter, which
showed the device in good place, with only mild
residual leak (Fig. 2B). The intervention was
uneventful. The procedure time was about
125 min. Fluoroscopy time was 16 min.
Pre procedure TEE
Large perimembranous VSD was covered by tri-
cuspid aneurysmal tissue with some inlet exten-
sion. The VSD from LV side measured about
10 mm while from the RV side there were many ex-
its, and the largest defect was about 5 mm (Fig. 3A).ing the VSD with multiple fenestrations. (B) Lateral projection after
Figure 3. (A) Trans-esophageal echocardiography (2D and color) showing the VSD with aneurysmal tricuspid valve tissue and the large left-to-
right shunt. (B) Trans-esophageal echocardiography (2D and color) showing the duct occluder device well seated within the aneurysmal tissue
and minimal residual left-to-right shunt across the ventricular septal defect (VSD). AoV: Aortic valve, LA: left atrium, LV: left ventricle, RA: right
atrium, RV: right ventricle.
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Amplatzer 8  6 mm duct occluder was de-
ployed in the sac of aneurysmal tissue with small
residual leak from its lower aspect and only mild
tricuspid valve regurgitation (Fig. 3B).Follow up
On follow up, no clinical nor laboratory findings
were suggestive for hemolysis, and ECG showed
normal sinus rhythm with no heart block. Chest
X-ray showed the device in position. Post-inter-
vention echo revealed the device in an excellent
position, with only mild TR, as before theprocedure. There was a tiny (2 mm) residual leak
as shown by color Doppler (Fig. 4). The infant
was discharged after 3 days on Aspirin 5 mg/kg/
day for 6 months. Two weeks later, the infant
started to gain more weight (5.3 kg). Since the
VSD device closure, he remains clinically stable
with no symptoms or signs of congestive
heart failure. Anti-failure medications were
discontinued.Discussion
Transcatheter closure of VSD was introduced in
the late 80s and early 90s [6–8]. While closure of
Figure 4. Trans-thoracic echocardiography (2D and color) at follow up showing the duct occluder device in good device with minimal residual
left-to-right shunt across it. LA: left atrium, LV: left ventricle, RA: right atrium, RV: right ventricle.
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membranous VSD, which came into discredit,
with previous studies finding a high rate of com-
plete atrio-ventricular block associated with this
procedure [9]. In general, transcatheter closure
has been limited to body weight above 10 kg
[10,11]. Our patient had Down syndrome, a body
weight of 4.8 kg, and he belonged to the categoryof patients in which surgical intervention is
usually indicated. Hybrid procedure as an alterna-
tive was contemplated but would have included
not only median thoracotomy, but also longer
intensive care unit. The facts were that the patient
had other associated congenital abnormalities,
failure to thrive and, importantly, his parents were
unwilling to have him undergo surgical repair. All
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native. The presence of a large aneurysmal tissue
covering the VSD made the risk of heart block
with transcatheter approach unlikely because
any device positioned in the aneurysmal tissue
will be a distance from the conduction tissue
[12]. We opted to perform this procedure on our
patient to spare him the potential complications
of surgical repair.
As the VSD had some inlet extension, we felt
that the newly released PFM VSD coil device
might interfere with the tricuspid valve leaflets
and its chordae, and possibly lead to more TR.
The muscular VSD device was excluded as it
would leave a 6 mm skirt from the RV side and
would potentially interfere with the normal move-
ment of the tricuspid valve. However, the duct oc-
cluder device had the right shape and hence
seemed to be the right choice for this infant.
Off-label use of Amplatzer ductal occluders in
perimembranous VSD has been reported [13,14].
As the entrance to the aneurysm from the LV side
measured 10 mm, we decided an 8  6 mm duct
occluder device would be the appropriate choice.
This device along with its 4 mm skirt was posi-
tioned in the aneurysmal sac completely and away
from the crest of the interventricular septum.
After critical exploration with TEE and by fluoros-
copy, the device was successfully released.
We believe that in such an aneurysmatic VSD
and in infants with such low body weight, with
or without association of Down syndrome, a trans-
catheter approach with its miniaturized devices
and delivery systems, either with the PFM Le coil
or with a duct occluder device, might be a good
alternative to spare such infants the potential
complications of surgery.
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